One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
New light on the activators of factor XI in venous thromboembolism
The new America First Global Health Strategy goes back to the future
Catch-up growth after switch to asciminib in a twin with chronic myeloid leukaemia
The impact of war on the respiratory health of civilians in Gaza
Views on the upcoming Lancet Commission on disability and health
Views on the upcoming Lancet Commission on disability and health
Views on the upcoming Lancet Commission on disability and health – Authors' reply
HCV response-guided therapy: is shorter always better? – Authors' reply
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial
Contemporary, non-invasive imaging diagnosis of chronic coronary artery disease
